Skip to main content

Zepzelca Prices, Coupons, Copay Cards & Patient Assistance

Zepzelca (lurbinectedin) is a member of the alkylating agents drug class and is commonly used for Small Cell Lung Cancer.

The cost for Zepzelca 4 mg intravenous powder for injection is around $8,381 for a supply of 1 powder for injection, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Zepzelca is available as a brand name drug only, a generic version is not yet available. View generic Zepzelca availability for more details.

Zepzelca prices

Intravenous Powder For Injection

Quantity Per unit Price
1 $8,380.85 $8,380.85

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Zepzelca Coupons, Copay Cards and Rebates

Zepzelca offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Zepzelca Savings Card

Eligible commercially insured patients may pay as little as $10 per prescription subject to an annual maximum savings amount; for additional information contact the program at 833-533-5299.

Applies to:
Zepzelca
Number of uses:
Per prescription per year

Form more information phone: 833-533-5299 or Visit website

Patient Assistance & Copay Programs for Zepzelca

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: Patient Access Network Foundation (PAN)

Eligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Zepzelca (lurbinectedin) Injection; IV

More information please phone: 866-316-7263 Visit Website

Provider: JazzCares: Zepzelca

Eligibility requirements:
  1. Must have no prescription coverage for needed medication
  2. At or below 400% of FPL
  3. FDA-approved diagnosis
  4. Must be a US resident and treated by a US licensed healthcare provider
  5. Eligibility determined on a case-by-case basis. Co-payment assistance, and patient assistance programs are available for eligible patients.
Applicable drugs:
  • Zepzelca (lurbinectedin) Injection; IV

More information please phone: 833-533-5299 Visit Website

Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.